Compare UNFI & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UNFI | WGS |
|---|---|---|
| Founded | 1976 | 2017 |
| Country | United States | United States |
| Employees | 25600 | 1300 |
| Industry | Food Distributors | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 1996 | N/A |
| Metric | UNFI | WGS |
|---|---|---|
| Price | $46.95 | $69.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $44.71 | ★ $120.71 |
| AVG Volume (30 Days) | ★ 637.3K | 628.0K |
| Earning Date | 06-09-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $0.47 | $29.98 |
| Revenue Next Year | $2.18 | $25.92 |
| P/E Ratio | ★ $195.16 | $1,251.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $21.27 | $55.17 |
| 52 Week High | $49.84 | $170.87 |
| Indicator | UNFI | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 58.02 | 49.94 |
| Support Level | $43.08 | $68.55 |
| Resistance Level | $47.59 | $95.75 |
| Average True Range (ATR) | 1.59 | 4.26 |
| MACD | -0.02 | 1.54 |
| Stochastic Oscillator | 55.08 | 73.04 |
United Natural Foods Inc is a wholesale distributor of natural, organic and specialty foods and nonfood products across North America. The company's products consist of national, regional and private label brands grouped into grocery and general merchandise, produce, perishables and frozen foods, nutritional supplements and sports nutrition, bulk and foodservice products, and personal care items. United Natural Foods serves various retail formats including conventional supermarket chains, natural product superstores, independent retail operators and foodservice channels such as e-commerce platforms. The company's operations are comprised of principal divisions: the wholesale division; the retail division; and other.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.